Zepbound goes into the abdomen, the thigh, or the back of the upper arm. Those are the three sites in Lilly’s prescribing information, and the label adds one detail most guides skip: the upper arm is described as a site another person injects for you.
The question underneath most searches here is whether the site changes anything. It does not. Lilly’s label states that similar exposure was achieved with subcutaneous administration of tirzepatide in the abdomen, thigh, or upper arm. Same drug absorbed, wherever you put it.
So site choice is not a lever for making Zepbound work better. It is a lever for protecting your skin so that every future dose keeps absorbing predictably.
The three sites, and what each is actually like
Abdomen. The default for most people, and the easiest site to do well. There is usually enough subcutaneous fat to pinch, you can see what you are doing, and the surface area is large enough to rotate around for weeks without repeating yourself. Stay on the softer tissue at least two inches from the navel, as Lilly specifies, and away from any scars.
Thigh. The front and outer thigh, roughly the middle third between hip and knee. Easy to reach sitting down. It tends to sting slightly more than the abdomen for people who carry less fat there, which is a comfort difference rather than a safety one. How much a site stings is individual, so it is worth trying each rather than assuming.
Back of the upper arm. The fleshy area at the back, and the site Lilly frames as one someone else injects. The reason is practical: reaching around to your own triceps makes it hard to pinch the tissue and keep the pen flat, and that is how injections end up too shallow or into muscle. If you have someone who can help, the arm is a genuinely useful fourth position in a rotation.
Does injection site matter for Zepbound?
No, not for how much drug you absorb. This is worth stating plainly because a lot of advice implies otherwise.
The label’s pharmacokinetics section is unambiguous: exposure is similar across the abdomen, thigh, and upper arm. Novo’s semaglutide labelling says the same thing for Ozempic and Wegovy, so it holds for both of the molecules most people are on. We have not checked the older GLP-1s, so treat it as true of semaglutide and tirzepatide rather than of the whole class.
What site choice does affect:
- Comfort. Some sites sting more for you than others. That is real, individual, and worth testing rather than predicting.
- Tissue health over months. This is the one that matters, and it is entirely under your control.
- Absorption consistency once tissue is damaged. Lipohypertrophy, the firm fatty lumps that build up where you inject repeatedly, absorbs unpredictably. That is how a site you have overused starts producing inconsistent weeks.
So the honest framing is that rotation is not going to make your dose work better this week. It is going to stop a site from becoming one that works worse in six months.
Rotate with every dose
Lilly’s instruction is direct: rotate injection sites with each dose.
Weekly dosing makes this deceptively easy to neglect. A daily injector notices immediately when a spot is sore. On a weekly drug you can use the same favourite square inch of abdomen for six months without ever feeling like you are overdoing it, and that is precisely how lipohypertrophy develops. The lumps are usually painless, so the first sign is often an unexplained change in how a week goes.
A four-site rotation gives every spot roughly a month to recover:
| Week | Site |
|---|---|
| 1 | Left abdomen |
| 2 | Right thigh |
| 3 | Right abdomen |
| 4 | Left thigh |
If you have someone who can inject the back of your arms, a six-week rotation adds left and right arm and stretches the recovery window further.
Within a site, move the exact spot too. “Left abdomen” is a palm-sized area, not a point. Shift an inch or two each time you come back to it.
Four weeks is exactly long enough to forget where you were. Regimen keeps the rotation for you and tells you the next site when your dose is due.
Track your rotation freeWhat to avoid
- Skin that is bruised, tender, red, hard, or scarred. Damaged tissue absorbs unpredictably.
- Any lump you can feel. If you find a firm patch, stop using that area entirely and give it months, not weeks.
- Within two inches of the navel, or over a scar. Lilly specifies the two-inch clearance; the tissue there is fibrous and the injection is more likely to sit wrong.
- Muscle. Zepbound is subcutaneous. If you are lean and worried about depth, pinch the skin and inject into the fold.
Novo’s guidance for semaglutide adds a point worth carrying over if you also use insulin: you may inject in the same body region, but the two injections should not be adjacent to each other, and the products should never be mixed. Lilly does not spell this out for Zepbound, so keep them clearly separated and ask your prescriber how they want them spaced.
If a spot bleeds a little afterwards, press gently with gauze or a cotton ball. Do not rub it.
Injection site reactions are worth expecting rather than being alarmed by: Lilly’s trials put them at 6 to 8 percent depending on dose, against 2 percent on placebo. Redness or a small lump that settles within a few days is common. Anything that persists, spreads, or keeps recurring in the same spot is worth raising with your prescriber.
Keeping track of rotation
The reason people stop rotating is not that they disagree with it. It is that four weeks later, nobody remembers which thigh they used.
Regimen logs the site with every dose and shows your rotation history as a body map, so the next site is already decided when you pick up the pen. It tracks how you respond week to week too, which is what turns an overused site into something you can see rather than guess at. Free for one compound, no time limit and no card.
Get Regimen freeA paper note works as well, as long as it survives four weeks. What does not work is memory.
Sources
Injection sites, the rotation instruction, the exposure statement, the injection-site-reaction rates and the co-injection rule come from Lilly’s Zepbound prescribing information and Instructions for Use. The semaglutide comparisons, the insulin guidance and the bleeding instruction come from Novo Nordisk’s Ozempic prescribing information, revised May 2026. The two-inch clearance from the navel is stated by BOTH manufacturers: Lilly in the KwikPen Instructions for Use and its patient guidance, Novo in the Ozempic and Wegovy Instructions for Use. It does not appear in Lilly’s single-dose pen IFU.
This article is for tracking and education. It is not medical advice, and dosing or administration questions belong with your prescriber.
Frequently asked questions
Where do you inject Zepbound?
The abdomen, the thigh, or the back of the upper arm. Lilly's prescribing information says to inject Zepbound subcutaneously in the abdomen or thigh, and that another person should inject it in the back of the upper arm. That last detail matters: the label frames the arm as a site someone else injects for you, because reaching the back of your own arm at the right angle is awkward.
Does the injection site change how well Zepbound works?
No. Lilly's label states that similar exposure was achieved with subcutaneous administration of tirzepatide in the abdomen, thigh, or upper arm. Your body absorbs the same amount of drug from all three. That is the direct answer to the most common question about this, and it means site choice is about comfort and skin health rather than getting more out of your dose.
What is the best place to inject Zepbound?
Whichever of the three approved sites you can reach comfortably and can rotate reliably. Since exposure is the same everywhere, there is no site that works better. Most people default to the abdomen because it is the easiest to see and pinch, and it has the most surface area to rotate around. If your abdomen is sore or bruised, switch to a thigh that week.
How often should you rotate Zepbound injection sites?
Every dose. The label says to rotate injection sites with each dose. Because Zepbound is weekly, it is easy to fall into using the same favourite spot for months, which is exactly how you develop lipohypertrophy, the firm fatty lumps that absorb erratically. A four-site rotation gives each spot about a month to recover.
Can you inject Zepbound in the same place every week?
You should not. Repeatedly injecting the same square of tissue causes lipohypertrophy over months. The lumps are usually painless, which is why people do not notice, and tissue that has changed absorbs unpredictably. Rotating is a small habit that protects the reliability of every future dose.
Can you inject Zepbound in your arm yourself?
The label describes the back of the upper arm as a site another person injects. Nothing physically stops you reaching it, but the angle makes it hard to pinch the tissue and keep the pen flat against the skin, which is how you end up injecting too shallow or into muscle. If you have someone who can help, the arm is a useful fourth site. If not, the abdomen and both thighs give you plenty to rotate around.
Can you inject Zepbound in the glute?
The glute is not one of the three sites in Zepbound's label. Regimen's peptide guides cover glute injections for compounds where that site is conventional, but for Zepbound specifically, stay with the abdomen, thigh, and back of the upper arm that Lilly lists. There is no absorption advantage to be gained by going outside the label.
How far from the belly button should you inject Zepbound?
At least two inches, and this is specified rather than convention. Lilly states it in the Zepbound KwikPen Instructions for Use and in its patient-facing how-to-use guidance, and Novo states the same two inches for Ozempic and Wegovy. Note that the single-dose pen IFU does not repeat the distance, so if that is the device you have, the two-inch rule still applies from the other Lilly materials. The tissue immediately around the navel is tougher and more fibrous, so stay clear of it and of any scars.
Does it hurt more in the thigh than the stomach?
Comfort varies by body composition, and most people settle on the abdomen because there is usually more subcutaneous fat to inject into there. If the thigh consistently stings for you, that is a reason to favour another site, not a sign anything is wrong. Worth knowing separately: injection site reactions are not rare on Zepbound. Lilly's trials reported them in 6 percent of patients at 5 mg and 8 percent at 10 and 15 mg, against 2 percent on placebo, and in 11.3 percent of patients who developed anti-tirzepatide antibodies.
Can you inject Zepbound and insulin in the same area?
Lilly is stricter than people assume here. The Zepbound Instructions for Use say not to mix Zepbound with any other medicine and not to inject it in the same injection site used for other medicines. Novo's rule for semaglutide is slightly looser: the same body region is acceptable as long as the injections are not adjacent, and the products are never mixed. Either way, keep the two clearly separated and confirm the spacing with your prescriber.
